Matthias A Hediger
University of Bern
Bern, Switzerland

Robert Burrier
EMD Chemicals, Inc.
Madison, WI, USA

Ken-ichi Inui
Kyoto University
Kyoto, Japan

Yoshikatsu Kanai

Osaka University
Osaka, Japan

Bruno Stieger

University of Zürich
Zürich, Switzerland


BioMedical Transporters 2009 will review the physiological, biomedical and pharmaceutical aspects of membrane transporters. The Conference offers scientists to learn about the most recent breakthroughs in the membrane transport field while interacting with the world leading experts in this field from both industry and academia. The conference will also provide a great opportunity to basic scientists to discuss university-industry collaborations. The diversity of participants and speakers will serve to enhance networking between scientists from different countries.

The expected number of participants for BioMedical transporters 2009 is 150. The participants are usually comprised of a mixture of scientists from Switzerland/Europe (~55%), the United States (~30%), Japan (~10%) and other countries (~5%), as predicted based on previous BioMedical Transporters conferences. About 30% of the participants will be from industry and the remainder from academia.

A list of topics covered at BioMedical Transporters 2009 is shown on the right.

Seepark Congress Center

The conference will be held at the Seepark Congress Center, a gorgeous and newly renovated conference facility. From there you'll have a beautiful view of the snow-capped mountains. The WEB sites for the Seepark hotel you can find at:

Seepark Center
Congress Hall

For a map please click HERE
For the photogallery please click HERE

  Session Topics:
Glucose transporters in health and disease, and therapeutic perspectives.

Structural biology and molecular dynamics of membrane transporters.

SLC solute carriers: Physiology, genetics and pharmacology.

ABC transporters: Pharmaceutical aspects.

Folate transporters: Physiological and pharmacological relevance.

Metabolomics and role of membrane transporters.

Tight junctions: Novel aspects at all fronts of investigation.

Lipid and nucleoside transporters: Biomedical and pharmacological aspects.